Clinical Trial Results:
            A 24-month, multicenter, randomized, open label non inferiority study of efficay and safety comparing concentration- controlled Certican in two doses (1.5 and 3.0 mg/day starting doses) with reduced Neoral versus 1.44 Myfortic with standard dose Neoral in de-novo renal transplant recipients
    
|     Summary | |
|     EudraCT number | 2005-002854-22 | 
|     Trial protocol | IT GB SK SE | 
|     Global completion date | 
                                    18 Aug 2009
                             | 
|     Paediatric regulatory details | |
|     Is the trial part of an agreed EMA paediatric investigation plan? | 
                                        No
                                 | 
|     Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | 
                                        No
                                 | 
|     Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | 
                                        No
                                 | 
|     Results information | |
|     Results version number | v1(current) | 
|     This version publication date | 
                                    15 Apr 2016
                             | 
|     First version publication date | 
                                    15 Apr 2016
                             | 
|     Other versions | |
|     Summary report(s) | CRAD001A2309 CT.gov results public | 
            Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to            Commission Guideline 2012/C 302/03
            for further information.    
 
				
